Evaluation of an oscillating-rotating toothbrush with micro-vibrations versus a sonic toothbrush for the reduction of plaque and gingivitis: results from a randomized controlled trial.


Journal

International dental journal
ISSN: 1875-595X
Titre abrégé: Int Dent J
Pays: England
ID NLM: 0374714

Informations de publication

Date de publication:
Apr 2020
Historique:
entrez: 4 4 2020
pubmed: 4 4 2020
medline: 9 4 2020
Statut: ppublish

Résumé

To compare a novel oscillating-rotating (O-R) electric rechargeable toothbrush with micro-vibrations to a marketed premium sonic toothbrush for reduction of gingivitis and plaque in an 8-week randomized controlled trial. Adult subjects with evidence of gingivitis and plaque were randomized to use either the novel O-R brush (Oral-B iO) or the sonic brush with sodium fluoride dentifrice twice daily. Assessments at baseline and week 8 included the Rustogi Modification of the Navy Plaque Index (RMNPI), Modified Gingival Index (MGI), and Gingival Bleeding Index (GBI). Gingivitis status ('healthy'/'not healthy') was classified per the American Academy of Periodontology/European Federation of Periodontology criteria. Ninety subjects were randomized to treatment and completed the study. Subjects had a mean age of 49.2 years; 68 were females. At baseline, the mean number (standard deviation [SD]) of bleeding sites for all subjects was 32.8 (16.43). At week 8, the O-R brush group had a higher percentage of 'healthy' gingiva subjects than the sonic brush group (84% vs. 53% P = 0.003). In the between-group comparisons at week 8, the O-R brush group showed statistically significantly greater reductions (P < 0.001) compared to the sonic group for MGI, GBI, and number of bleeding sites. The O-R brush group also had statistically significantly greater plaque removal (P ≤ 0.011) than the sonic brush group for whole mouth plaque as well as plaque in the proximal regions and along the gingival margin. The novel O-R electric toothbrush with micro-vibrations provided greater plaque and gingivitis reductions than the marketed premium sonic toothbrush over 8 weeks.

Identifiants

pubmed: 32243576
doi: 10.1111/idj.12569
pmc: PMC9379213
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

S16-S21

Subventions

Organisme : Procter & Gamble, Cincinnati

Informations de copyright

© 2020 FDI World Dental Federation.

Références

PLoS Pathog. 2015 Jul 30;11(7):e1004952
pubmed: 26226364
J Clin Dent. 2017 Mar;28(1 Spec No A):A13-28
pubmed: 28422461
J Clin Dent. 2015;26(3):80-5
pubmed: 26665291
Clin Prev Dent. 1986 Jan-Feb;8(1):3-6
pubmed: 3485495
Am J Dent. 2020 Feb;33(1):3-11
pubmed: 32056408
J Clin Periodontol. 2003 Oct;30(10):887-901
pubmed: 14710769
J Clin Dent. 2014;25(2):6-12
pubmed: 25122976
J Clin Dent. 2009;20(3):93-8
pubmed: 19711610
J Clin Dent. 2013;24(2):55-61
pubmed: 24282870
J Periodontol. 2018 Jun;89 Suppl 1:S46-S73
pubmed: 29926936
Am J Dent. 2014 Feb;27(1):56-60
pubmed: 24902407
Am J Dent. 2012 Oct;25(5):287-92
pubmed: 23243977
J Clin Dent. 2014;25(2):26-31
pubmed: 25122979
J Clin Dent. 1992;3(Suppl C):C9-12
pubmed: 1306676
Int J Dent Hyg. 2019 May;17(2):153-160
pubmed: 30375187
J Dent Res. 2003 Nov;82(11):929-32
pubmed: 14578508
J Periodontal Res. 1989 Jan;24(1):75-80
pubmed: 2524573
Am J Dent. 2014 Aug;27(4):179-84
pubmed: 25831599
Ann Periodontol. 1999 Dec;4(1):7-19
pubmed: 10863371
J Clin Periodontol. 2004 Dec;31(12):1122-7
pubmed: 15560816
J Clin Dent. 2018 Mar;29(1):27-32
pubmed: 29758154
J Periodontol (1930). 1965 May-Jun;36:177-87
pubmed: 14296927
Am J Dent. 2012 Sep;25 Spec No A(A):21A-26A
pubmed: 23248895
Am J Dent. 2013 Apr;26(2):68-74
pubmed: 24073528
J Clin Periodontol. 2015 Apr;42 Suppl 16:S77-91
pubmed: 25597787
Int J Dent Hyg. 2020 Feb;18(1):17-26
pubmed: 31050195
Cochrane Database Syst Rev. 2014 Jun 17;(6):CD002281
pubmed: 24934383
J Periodontal Res. 2017 Aug;52(4):651-665
pubmed: 28177120

Auteurs

Ralf Adam (R)

Procter & Gamble Service GmbH, Kronberg, Germany.

C Ram Goyal (C)

All Sum Research Center Ltd, Mississauga, ON, Canada.

Jimmy Qaqish (J)

All Sum Research Center Ltd, Mississauga, ON, Canada.

Julie Grender (J)

The Procter & Gamble Company, Mason, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH